Subcutaneous immunoglobulin in allogeneic hematopoietic cell transplant patients: A prospective study of feasibility, safety, and healthcare resource use-Reference-Cited by-同舟云学术

Subcutaneous immunoglobulin in allogeneic hematopoietic cell transplant patients: A prospective study of feasibility, safety, and healthcare resource use

Published:2021-12 Issue:4 Volume:14 Page:302-310
ISSN:1658-3876
Container-title:Hematology/Oncology and Stem Cell Therapy
language:en
Short-container-title:Hematology/Oncology and Stem Cell Therapy

Author:

Pasic Ivan^ORCID,Alanazi Wael,Dranitsaris George,Lieberman Lani,Viswabandya Auro,Kim Dennis Dong Hwan,Lipton Jeffrey H.,Michelis Fotios V.

Funder

CSL Behring LLC

Publisher

Elsevier BV

Subject

Oncology,Hematology,General Medicine

Reference32 articles.

1. Immune reconstitution after hematopoietic cell transplantation;Bosch;Curr Opin Hematol,2012

2. Allogeneic stem cell transplantation: low immunoglobulin levels associated with decreased survival;Norlin;Bone Marrow Transpl,2008

3. Factors influencing B lymphopoiesis after allogeneic hematopoietic cell transplantation;Storek;Blood,2001

4. Immunoglobulin G subclass deficiency and pneumococcal infection after allogeneic bone marrow transplantation;Sheridan;Blood,1990

5. Panels on behalf of the IH and NE. Evidence-based guidelines on the use of intravenous immune globulin for hematologic and neurologic conditions;Robinson;Transfus Med Rev,2007

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review of the cost and cost-effectiveness of immunoglobulin treatment in patients with hematological malignancies;International Journal of Technology Assessment in Health Care;2024

2. A single‐institution pre–post comparison of subcutaneous immunoglobulin replacement therapy in allogeneic haematopoietic cell transplantation recipients;British Journal of Haematology;2023-11-14

3. Safety and Efficacy of Hizentra® Following Pediatric Hematopoietic Cell Transplant for Treatment of Primary Immunodeficiencies;Journal of Clinical Immunology;2023-06-02

4. Safety and Efficacy of Hizentra ® Following Pediatric Hematopoietic Cell Transplant for Treatment of Primary Immunodeficiencies;2022-11-07

5. Controversies about immunoglobulin replacement therapy in HSCT recipients with hypogammaglobulinemia;Bone Marrow Transplantation;2022-04-19